Drug ID | DDPD00184 |
|
Drug Name | Nicotine | |
Molecular Weight | 162.2316 | |
Molecular Formula | C10H14N2 | |
CAS Number | 54-11-5 | |
SMILES | CN1CCC[C@H]1C1=CN=CC=C1 | |
External Links | ||
DRUGBANK | DB00184 | |
T3DB | T3D0799 | |
PubChem Compound | 89594 | |
PDR | 1824 | |
Drugs.com | Drugs.com Drug Page |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Caco-2 Permeability | -4.71 | - | -4.71 | - | ADME Research, USCD |
Log P | 1.17 | - | 1.17 | - | HANSCH,C ET AL. (1995) |
Boiling Point | 247.0 | ℃ | 247 | ℃ | PhysProp |
Melting Point | -79.0 | ℃ | -79 | ℃ | PhysProp |
Water Solubility | 1000000.0 | mg/L | 1000000 | mg/L | SEIDELL,A 1941) |
pKa | 8.5 | - | 8.5 | - | http://www.surgeongeneral.gov/library/reports/50-years-of-progress/sgr50-chap-5.pdf |
Log S | 0.79 | - | 0.79 | - | ADME Research, USCD |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
Clearance | 72.0 | L/h | 1.2 | L/min | adults; normal,healthy; Somking; | DRUGBANK | Clearance | 1.1 | L/h/kg | 18 | ml/min/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution | 2.5 | L/kg | 2.0-3 | L/kg | DRUGBANK | Volume of Distribution | 2.6 | L/kg | 2.6 | L/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Half-life | 2.0 | h | 1-3 | h | DRUGBANK | Half-life | 2.0 | h | 2 | h | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 | 24.0 | mg/kg | 24.0 | mg/kg | PO, oral; mouse; | DRUGBANK | Toxicity LD50 | 140.0 | mg/kg | 140.0 | mg/kg | skin/dermal; Rattus, Rat; | T3DB | Toxicity LD50 | 25.0 | mg/kg | 25.0 | mg/kg | subcutaneous injection, SC; Rattus, Rat; | T3DB | Toxicity LD50 | 5.9 | mg/kg | 5900.0 | ug/kg | Intraperitoneal, IP; mouse; | T3DB | Toxicity LD50 | 2.8 | mg/kg | 2.8 | mg/kg | intravenous injection, IV; Rattus, Rat; | T3DB | Toxicity LD50 | 24.0 | mg/kg | 24.0 | mg/kg | PO, oral; mouse; | T3DB |
Toxicity Lethal Dose | 50.0 | mg | 40-60 | mg | adults; human, homo sapiens; | T3DB |
Eliminate Route | 10.0 | % | ~10 | % | Urinary excretion; Unchanged drug; | DRUGBANK |
Protein Binding | 5.0 | % | <5 | % | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for adolescents | 24.0 | pieces/day | 24 | pieces/day | PO, oral | Nicotrol NS | nicotine | PDR |
Max dose for adolescents | 21.0 | mg/day | 21 | mg/day | skin/dermal | Nicotrol NS | nicotine | PDR |
Max dose for adolescents | 14.0 | mg/day | 14 | mg/day | skin/dermal | Nicotrol NS | nicotine | PDR |
Max dose for adults | 24.0 | pieces/day | 24 | pieces/day | PO, oral | Nicotrol NS | nicotine | PDR |
Max dose for adults | 21.0 | mg/day | 21 | mg/day | skin/dermal | Nicotrol NS | nicotine | PDR |
Max dose for adults | 20.0 | Lozenges/day | 20 | Lozenges/day | PO, oral | Nicotrol NS | nicotine | PDR |
Max dose for adults | 40.0 | sprays/day | 40 | sprays/day | nasal spray | Nicotrol NS | nicotine | PDR |
Max dose for adults | 64.0 | mg/day | 64 | mg/day | inhalation, IH | Nicotrol NS | nicotine | PDR |
Max dose for geriatric | 24.0 | pieces/day | 24 | pieces/day | PO, oral | Nicotrol NS | nicotine | PDR |
Max dose for geriatric | 21.0 | mg/day | 21 | mg/day | skin/dermal | Nicotrol NS | nicotine | PDR |
Max dose for geriatric | 20.0 | lozenges/day | 20 | lozenges/day | PO, oral | Nicotrol NS | nicotine | PDR |
Max dose for geriatric | 40.0 | sprays/day | 40 | sprays/day | nasal spray | Nicotrol NS | nicotine | PDR |
Max dose for geriatric | 64.0 | mg/day | 64 | mg/day | inhalation, IH | Nicotrol NS | nicotine | PDR |